Company CVAbout TTK Healthcare Ltd. 
TTK Healthcare Ltd.
Small Cap
Pharmaceuticals & Drugs
TTK Healthcare Limited, a TTK Group Company was incorporated in May 1958 as Orient Pharma and later renamed as TTK Pharma in Nov '81. The Company is the owner of famous Woodwards Gripewater brand. The Company operate into five main Strategic Business Units namely, Pharmaceuticals, Consumer Products, Medical Devices, Foods and Protective Devices divisions. It is engaged into Animal Welfare Products, Consumer Products, Medical Devices, Protective Devices and Foods Businesses.
Company Coordinates
Company Details
6 Cathedral Road , Chennai Tamil Nadu : 600086
Registrar Details
Data Software Research Co Pvt Ltd , 9 Pycroft Garden Road, Off Haddows Road, Nungambakkam, Chennai
Capital StructureCapital Structure
Present Equity Capital
INR 14.13 Cr
Number of Shares
1.41 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
02-Mar-2018
1.41
14.13
6364350
10
Amalgamation
30-Sep-2009
77.66
7.77
-101886
10
Buy Back of Shares
30-Sep-2009
77.66
7.77
-101886
10
Buy Back of Shares
30-Jun-2009
78.68
7.87
-219628
10
Buy Back of Shares
30-Jun-2009
78.68
7.87
-219628
10
Buy Back of Shares
31-Mar-2009
80.87
8.09
-22917
10
Buy Back of Shares
31-Mar-2009
80.87
8.09
-22917
10
Buy Back of Shares
02-Mar-2008
1.41
14.13
6364350
10
Amalgamation
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 2 Schemes (0.0%)
FIIs
Held by 10 FIIs (1.9%)
Promoter with highest holding
T T Krishnamachari & Co. Represented By Its Partners - Mr T T Jagannathan And Mr T T Raghunathan (67.46%)
Highest Public shareholder
Jupiter India Fund (1.52%)
Individual Investors Holdings
16.2%
Board of Directors
Management
Designation
Remuneration
T T Raghunathan
Executive Chairman
4.1 cr
R K Tulshan
Non-Exec & Non-Independent Dir
4.4 lacs
K Shankaran
Non-Exec & Non-Independent Dir
7.8 lacs
S Kalyanaraman
Whole Time Director & Secretar
3.02 cr
Vandana R Walvekar
Non-Exec. & Independent Dir.
3.2 lacs
Girish Rao
Non-Exec. & Independent Dir.
4.8 lacs
S Balasubramanian
Non-Exec. & Independent Dir.
5.4 lacs
N Ramesh Rajan
Non-Exec. & Independent Dir.
3.8 lacs
V Ranganathan
Non-Exec. & Independent Dir.
3.6 lacs
T T Mukund
Director
1.2 lacs
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceuticals - Tablets and Capsules
216.46
34.47%
Consumer Products
189.99
30.26%
Protective Devices
103.14
16.43%
Pharmaceuticals - Tablets and Capsules
Pharmaceuticals - Tablets and Capsules
Consumer Products
Consumer Products
Protective Devices
Protective Devices
Stock DNARevenue and Profits:
Net Sales:
205 Cr
(Quarterly Results - Dec 2024)
Net Profit:
17 Cr
Pharmaceuticals & Drugs
INR 1,696 Cr (Small Cap)
24.00
33
0.86%
-0.73
6.59%
1.58
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
